7 employees
Biotechnology company developing combination therapeutics for cancer
2021
$7M
from 4 investors over 4 rounds
Eigen Therapeutics raised $7M on December 8, 2022
Investors: Mount Pleasant Ventures, Bioverge and Hawktail
Eigen Therapeutics raised undisclosed on February 28, 2022
Investors: Bioverge